₩8,040.00 ($5.93)

+90.00 (+1.13%)

Weekly Expected Move ±3.2%

₩7524 ₩7782 ₩8040 ₩8298 ₩8556

KOE · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 34 · ₩227.5B mcap · 10M float · 0.965% daily turnover

Revenue

$574.9B -6.6% ▼

5Y CAGR: -1.1%

Gross Profit

$80.6B -5.3% ▼

5Y CAGR: -10.2%

Operating Income

$26.6B +9.1% ▲

5Y CAGR: -24.6%

Net Income

-$19.6B -208.5% ▼

EPS (Diluted)

$-666.18 -207.5% ▼

EBITDA

$46.3B -9.6% ▼

5Y CAGR: -17.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$593.1B	$575.9B	$579.6B	$615.6B	$574.9B
YoY Growth	-2.3%	-2.9%	+0.6%	+6.2%	-6.6%
Cost of Revenue	$462.8B	$472.9B	$498.5B	$530.6B	$494.3B
Gross Profit	$130.3B	$103.0B	$81.0B	$85.1B	$80.6B
Gross Margin	22.0%	17.9%	14.0%	13.8%	14.0%
R&D Expenses	$720M	$25M	$443M	$2.1B	$0
SG&A Expenses	$34.6B	$37.2B	$46.4B	$18.9B	$0
Operating Expenses	$38.6B	$41.9B	$50.7B	$60.4B	$53.9B
Operating Income	$91.6B	$61.0B	$30.3B	$24.4B	$26.6B
Operating Margin	15.4%	10.6%	5.2%	4.0%	4.6%
Interest Expense	$1.8B	$3.2B	$7.4B	$9.0B	$7.1B
Income Before Tax	$91.9B	$55.8B	$26.0B	$23.4B	-$24.0B
Tax Expense	$23.5B	$15.5B	$7.3B	$6.2B	-$4.4B
Net Income	$69.9B	$40.5B	$19.7B	$18.1B	-$19.6B
Net Margin	11.8%	7.0%	3.4%	2.9%	-3.4%
EPS (Diluted)	$2365.04	$1371.39	$674.49	$619.58	$-666.18
EBITDA	$105.3B	$73.5B	$50.5B	$51.2B	$46.3B
Shares Outstanding	30M	30M	29M	29M	29M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$147.4B	$142.1B	$136.7B	$164.1B	$151.8B	$122.2B	$136.9B	$127.2B
Cost of Revenue	$128.1B	$123.6B	$118.8B	$139.4B	$126.7B	$109.3B	$115.7B	$107.5B
Gross Profit	$19.4B	$18.5B	$17.9B	$24.7B	$25.1B	$12.9B	$21.2B	$19.7B
Gross Margin	13.1%	13.0%	13.1%	15.0%	16.5%	10.6%	15.5%	15.5%
R&D Expenses	$570M	$529M	$585M	$353M	$276M	$203M	$312M	$469M
SG&A Expenses	$13.1B	$13.2B	$12.3B	$11.6B	$4.7B	-$11.6B	$4.4B	$9.3B
Operating Expenses	$13.6B	$15.2B	$14.3B	$14.0B	$15.4B	$10.2B	$11.1B	$10.0B
Operating Income	$4.1B	$3.2B	$3.6B	$10.7B	$9.7B	$2.6B	$10.1B	$9.7B
Operating Margin	2.8%	2.3%	2.6%	6.5%	6.4%	2.2%	7.4%	7.7%
Interest Expense	$2.0B	$2.3B	$2.0B	$1.9B	$1.6B	$1.6B	$1.3B	$1.0B
Income Before Tax	$4.8B	$2.8B	$2.4B	$9.1B	$8.5B	-$44.1B	$29.3B	$9.8B
Tax Expense	$1.3B	$715M	$962M	$2.4B	$2.3B	-$10.1B	$6.9B	$2.8B
Net Income	$3.8B	$2.1B	$1.4B	$6.7B	$6.2B	-$33.9B	$22.4B	$6.9B
Net Margin	2.6%	1.5%	1.0%	4.1%	4.1%	-27.8%	16.3%	5.4%
EPS (Diluted)	$130.00	$74.18	$50.00	$237.51	$218.00	$-1171.18	$787.00	$244.98
EBITDA	$11.7B	$9.9B	$9.1B	$29.5B	$14.8B	-$7.2B	$14.3B	$13.7B
Shares Outstanding	29M	29M	28M	28M	28M	29M	29M	28M

200130.KQ KOE